ES2141249T3 - Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores. - Google Patents

Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.

Info

Publication number
ES2141249T3
ES2141249T3 ES94924756T ES94924756T ES2141249T3 ES 2141249 T3 ES2141249 T3 ES 2141249T3 ES 94924756 T ES94924756 T ES 94924756T ES 94924756 T ES94924756 T ES 94924756T ES 2141249 T3 ES2141249 T3 ES 2141249T3
Authority
ES
Spain
Prior art keywords
tumors
formation
identification
human
capacity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94924756T
Other languages
English (en)
Inventor
Hinrich Johann Abken
Winfried Albert
Herbert Jungfer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Application granted granted Critical
Publication of ES2141249T3 publication Critical patent/ES2141249T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA INVENCION SE REFIERE A COMPLEJOS DE PROTEINA DNA, PROTEINAS, SECUENCIAS DNA Y ANTICUERPOS QUE SON ADECUADOS PARA SU UTILIZACION EN LA DETECCION DE CELULAS CON CAPACIDAD DE PROLIFERACION ILIMITADA O DE FORMACION DE TUMORES, PROCESO PARA LA OBTENCION DE TALES PROTEINAS O SECUENCIAS DNA Y METODO DE IDENTIFICACION DE CELULAS HUMANAS Y ANIMALES CON CAPACIDAD DE PROLIFERACION ILIMITADA O DE FORMACION DE TUMORES, UTILIZANDO TALES PROTEINAS, SECUENCIAS DNA O ANTICUERPOS.
ES94924756T 1993-07-15 1994-07-13 Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores. Expired - Lifetime ES2141249T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4323727A DE4323727A1 (de) 1993-07-15 1993-07-15 Verfahren zur Identifizierung von menschlichen und tierischen Zellen mit der Fähigkeit zu unbegrenzter Proliferation oder zur Tumorbildung

Publications (1)

Publication Number Publication Date
ES2141249T3 true ES2141249T3 (es) 2000-03-16

Family

ID=6492889

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94924756T Expired - Lifetime ES2141249T3 (es) 1993-07-15 1994-07-13 Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.

Country Status (9)

Country Link
US (1) US6503706B1 (es)
EP (1) EP0708841B1 (es)
JP (1) JPH09500272A (es)
CN (1) CN1129958A (es)
AT (1) ATE186575T1 (es)
CA (1) CA2166976A1 (es)
DE (2) DE4323727A1 (es)
ES (1) ES2141249T3 (es)
WO (1) WO1995002701A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19509898A1 (de) * 1995-03-18 1997-06-05 Boehringer Mannheim Gmbh, 68305 Mannheim Verfahren zur Messung Transkriptions-regulatorischer Aktivitäten von DNS-Sequenzen
US6566583B1 (en) * 1997-06-04 2003-05-20 Daniel Facciotti Schizochytrium PKS genes
DE19725133A1 (de) * 1997-06-13 1998-12-17 Micromet Ges Fuer Biomedizinis Nachweis von seltenen Zellen
WO1999018235A1 (de) * 1997-10-07 1999-04-15 Hinrich Abken Verfahren zum nachweis sowie zur gewinnung oder beseitigung von human- oder säugerzellen mit gestörter zellzykluskontrolle ode r der fähigkeit zu unbegrenzter proliferation oder zur tumorbildung
US7247461B2 (en) * 1999-01-14 2007-07-24 Martek Biosciences Corporation Nucleic acid molecule encoding ORFA of a PUFA polyketide synthase system and uses thereof
US20070244192A1 (en) * 1999-01-14 2007-10-18 Martek Biosciences Corporation Plant seed oils containing polyunsaturated fatty acids
US7211418B2 (en) * 1999-01-14 2007-05-01 Martek Biosciences Corporation PUFA polyketide synthase systems and uses thereof
US7217856B2 (en) * 1999-01-14 2007-05-15 Martek Biosciences Corporation PUFA polyketide synthase systems and uses thereof
US8003772B2 (en) * 1999-01-14 2011-08-23 Martek Biosciences Corporation Chimeric PUFA polyketide synthase systems and uses thereof
AU2001283042A1 (en) * 2000-07-29 2002-02-13 Genaissance Pharmaceuticals, Inc. Haplotypes of the il12b gene
IL137905A0 (en) * 2000-08-16 2001-10-31 Nathan Citri Direct selection of protein complexes relevant to the physiological or diagnostic context of a biological specimen
DE10046318A1 (de) * 2000-09-19 2002-03-28 Hinrich Abken Verfahren zum Nachweis von Tumorzellen
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
KR101524398B1 (ko) 2006-03-15 2015-06-04 디에스엠 아이피 어셋츠 비.브이. Ｐｕｆａ 폴리케티드 신타제 시스템을 이용한 이종 생물체내 다불포화 지방산의 제조
ES2717102T3 (es) * 2009-03-19 2019-06-19 Dsm Ip Assets Bv Moléculas de ácido nucleico de ácido graso poliinsaturado sintasas, y polipéptidos, composiciones y métodos de preparación y usos de los mismos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6133199A (ja) * 1984-05-25 1986-02-17 Asahi Chem Ind Co Ltd γ−インタ−フエロン活性を有するポリペプチド
DE4218945A1 (de) * 1992-06-10 1993-12-16 Boehringer Mannheim Gmbh DNA zur Immortalisierung von humanen oder tierischen Zellen

Also Published As

Publication number Publication date
EP0708841A1 (de) 1996-05-01
DE4323727A1 (de) 1995-03-09
US6503706B1 (en) 2003-01-07
CA2166976A1 (en) 1995-01-26
CN1129958A (zh) 1996-08-28
DE59408917D1 (de) 1999-12-16
WO1995002701A1 (de) 1995-01-26
JPH09500272A (ja) 1997-01-14
EP0708841B1 (de) 1999-11-10
ATE186575T1 (de) 1999-11-15

Similar Documents

Publication Publication Date Title
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
BG100771A (bg) Хематопоетичен протеин и материали и методи за неговото получаване
DE69131961D1 (de) Für die reinigung bestimmte klonierung von peptiden
EA200001023A1 (ru) Специфическое в отношении fapa-(протеин альфа активации фибробласта) антитело с повышенной продуктивностью
NO20014584D0 (no) Proteinisolering og -analyse
DK0961780T3 (da) Proteinmarkörer for lungecancer og anvendelse deraf
TR199900666T2 (xx) �nsan paratormonu ile ilgili peptidlere kar�� antikor.
ATE332368T1 (de) Selektion von proteinen mittels rns-protein fusionen
DE69733247D1 (de) Humanisiertes grünes-fluoreszenzprotein und methoden
FI900808A0 (fi) Humant mannos bindande protein.
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
DE69535719D1 (de) Fas-antigenbindender ligand
FI970979A0 (fi) Muokatut ihmisen C3-proteiinit
NO885013D0 (no) FremgangsmŸte for fremstilling av bionedbrytbare mikrokapsler av vannopplelige peptider og proteiner, samt mikroka psler oppnŸdd ved fremgangsmŸten.
SE8801701D0 (sv) Production technology based on enzymic method
FR2660757B1 (fr) Procede d'identification ou de dosage de proteines et applications.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
DK1082423T3 (da) Cyclin E2-gener og -proteiner
ATE265533T1 (de) Saeugetierchemokine
GEP20043386B (en) β -Amyloid Peptide-Binding Proteins and Polynucleotides Encoding the Same
DE69734586D1 (de) Retinoid-metabolisierendes protein
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
NO901461L (no) Antistoffer mot retinoblastom-genprodukt og anvendelse derav.
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
EP0950062A4 (en) PROTEIN MARKER FOR OESOPHAGUS CANCER

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 708841

Country of ref document: ES